Physician Wealth Advisors
INGR icon

Physician Wealth Advisors’s Ingredion INGR Stock Holding History

Physician Wealth Advisors’s Portfolio INGR Stock Details INGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-10
Closed -$948 – 2531
2026
Q2 		$948 Buy
10
+6
+150% +$634 ﹤0.01% 1864
2026
Q1 		$451 Hold
4
– – ﹤0.01% 1960
2025
Q4 		$442 Buy
+4
New +$451 ﹤0.01% 1940

Other funds holding INGR

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Yacktman Asset Management
Yacktman Asset Management Austin, Texas $8.38B AUM 19.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Cooke & Bieler
Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Physician Wealth Advisors's INGR Position: Q3 2026 in Review

Physician Wealth Advisors sold out of Ingredion (INGR) in Q3 2026, closing a stake of 10 shares — an estimated $948 sold.

Physician Wealth Advisors first reported a position in INGR in Q4 2025 and held it in 3 quarters. The position peaked at $948 in Q2 2026. 352 funds tracked by Wall St. Rank hold INGR as of Q3 2026.

  • Physician Wealth Advisors reported no remaining Ingredion position as of Q3 2026 after selling out during the quarter.
  • Physician Wealth Advisors sold 10 Ingredion shares in Q3 2026, an estimated $948.
  • Physician Wealth Advisors first reported a position in Ingredion in Q4 2025 and held it in 3 quarters.
  • Physician Wealth Advisors's Ingredion position peaked at $948 in Q2 2026.
  • 352 funds tracked by Wall St. Rank held Ingredion as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.